Identification of neuropeptide FF-related peptides in human cerebrospinal fluid by mass spectrometry

FEBS Letters

Volumn 532, Issue 3, 2002, Pages 313-318

  Burlet Schiltz, Odile ^a   Mazarguil, Honoré ^a   Sol, Jean Christophe ^b   Chaynes, Patrick ^b   Monsarrat, Bernard ^a   Zajac, Jean Marie ^a   Roussin, Anne ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b CHU RANGUEIL   (France)

Author keywords

Electrospray tandem mass spectrometry; Human cerebrospinal fluid; Nanospray ion trap tandem mass spectrometry; Neuropeptide FF

Indexed keywords

NEUROPEPTIDE; NEUROPEPTIDE AF; NEUROPEPTIDE FF; NEUROPEPTIDE SF; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROCEPHALUS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; CEREBROSPINAL FLUID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PEPTIDES; RADIOIMMUNOASSAY; TIME FACTORS;

BOVINAE; RODENTIA;

EID: 0037132557     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(02)03686-4     Document Type: Article

References (22)

1. Liu Q., Guan X.M., Martin W.J., McDonald T.P., Clements M.K., Jiang Q., Zeng Z., Jacobson M., Williams D.L. Jr., Yu H., Bomford D., Figueroa D., Mallee J., Wang R., Evans J., Gould R., Austin C.P. J. Biol. Chem. 40:2001;36961-36969.
2. Zajac J.-M. Trends Pharmacol. Sci. 22:2001;63.
3. Kotani M., Mollereau C., Detheux M., Le Poul E., Brezillon S., Vakili J., Mazarguil H., Vassart G., Zajac J.-M., Parmentier M. Br. J. Pharmacol. 133:2001;138-144.
4. Perry S.J., Huang E.Y., Cronk D., Bagust J., Sharma R., Walker R.J., Wilson S., Burke J.F. FEBS Lett. 409:1997;426-430.
5. Vilim F.S., Aarnisalo A.A., Nieminen M.L., Lintunen M., Karlstedt K., Kontinen V.K., Kalso E., States B., Panula P., Ziff E. Mol. Pharmacol. 55:1999;804-811.
6. Yang H.-Y.T., Fratta W., Majane E.A., Costa E. Proc. Natl. Acad. Sci. USA. 82:1985;7757-7761.
7. Gicquel S., Mazarguil H., Desprat C., Allard M., Devillers J.-P., Simonnet G., Zajac J.-M. J. Med. Chem. 37:1994;3477-3481.
8. Yang, H.-Y.T. and Martin, B.-M. (1995) Soc. Neurosci. Abstr., San Diego, CA, 21, 760.
9. Bonnard E., Burlet-Schiltz O., Frances B., Mazarguil H., Monsarrat B., Zajac J., Roussin A. Peptides. 22:2001;1085-1092.
10. Ukena K., Iwakoshi E., Minakata H., Tsutsui K. FEBS Lett. 512:2002;255-258.
11. Hinuma S., Shintani Y., Fukusumi S., Iijima N., Matsumoto Y., Hosoya M., Fujii R., Watanabe T., Kikuchi K., Terao Y., Yano T., Yamamoto T., Kawamata Y., Habata Y., Asada M., Kitada C., Kurokawa T., Onda H., Nishimura O., Tanaka M., Ibata Y., Fujino M. Nature Cell Biol. 2:2000;703-708.
12. Nilsson C.L., Karlsson G., Bergquist J., Westman A., Ekman R. Peptides. 19:1998;781-789.
13. Gicquel S., Mazarguil H., Allard M., Simonnet G., Zajac J.-M. Eur. J. Pharmacol. 222:1992;61-67.
14. Dupouy V., Zajac J.-M. Synapse. 24:1996;282-296.
15. Sundblom D.M., Panula P., Fyhrquist F. Peptides. 16:1995;347-350.
16. Sundblom D.M., Kalso E., Tigerstedt I., Wahlbeck K., Panula P., Fyhrquist F. Peptides. 18:1997;923-927.
17. Sundblom D.M., Hyrkkö A., Fyhrquist F. Peptides. 19:1998;1165-1170.
18. Poca M.A., Mataro M., Sahuquillo J., Catalan R., Ibanez J., Galard R. J. Neurol. Neurosurg. Psychiatry. 70:2001;298-304.
19. Gouardères, C., Quelven, I., Mollereau, C., Mazarguil, H., S.Q.J., R. and Zajac, J.-M. (2002) Neuroscience 115, 349-361.
20. Jhamandas, K., Sutak, M., Gouardères, C. and Zajac, J.-M. (2001) Joint Pharmacological Society of Canada, British Pharmacology Society and Western Pharmacological Society Meeting, Vancouver (Canada), March 25-29.
21. Allard M., Jordan D., Zajac J.-M., Ries C., Martin D., Monkouanga D., Kopp N., Simmonet G. Brain Res. 633:1994;127-132.
22. Biemann K. Methods Enzymol. 193:1990;886-887.